Safety concerns about digoxin after acute myocardial infarction.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 10437870.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We examined clinical outcomes associated with non-randomised digoxin therapy in a postmyocardial infarction population with clinical heart failure (AIRE study). Our results raise concern about the safety of digoxin in this population.
Medical subject headings
- Cardiotonic Agents
- Digoxin
- Heart Failure
- Myocardial Infarction